HCPCS Level IIdrugActive
J1299
Inj, eculizumab, 2 mg
BETOS: O1E
Effective: 2025-04-01
Referenced in 1 policies
Description
Injection, eculizumab, 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Soliris
Manufacturer
Alexion Pharmaceuticals, Inc.
HCPCS Dosage
2 MG
Billing Units
150.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.